SFM
NBRV

Sphera Funds Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Sphera Funds Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-630
Closed -$1.5M – 133
2015
Q4 		$1.5M Sell
630
-70
-10% -$171K 0.22% 98
2015
Q3 		$1.66M Buy
+700
New +$1.86M 0.21% 103

Other funds holding NBRV

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sphera Funds Management's NBRV Position: Q1 2016 in Review

Sphera Funds Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2016, closing a stake of 630 shares — an estimated $1.5M sold.

Sphera Funds Management first reported a position in NBRV in Q3 2015 and held it in 2 quarters. The position peaked at $1.66M in Q3 2015. 20 funds tracked by Wall St. Rank hold NBRV as of Q1 2016.

  • Sphera Funds Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 630 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2016, an estimated $1.5M.
  • Sphera Funds Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 2 quarters.
  • Sphera Funds Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1.66M in Q3 2015.
  • 20 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.